cpl500036
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 20, 2018 (NCT03873324)
Timeline
Indications
Mechanism of action
- Phosphodiesterase 10AINHIBITOR
PDE10A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05297201 | Phase 2 | Nov 2, 2021 | Celon Pharma SA, Government of Poland |
| NCT05278156 | Phase 2 | May 19, 2021 | Celon Pharma SA, Government of Poland |
| NCT03873324 | Phase 1 | Dec 20, 2018 | Celon Pharma SA, Government of Poland |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Celon Pharma SA | For profit | 3 | 3 | 2 | 2018 |
| Government of Poland | Government | 3 | 0 | 2 | 2018 |
2 organizations
Page 1 / 1